{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:23:31Z","timestamp":1747164211042,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcyt.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:33:08Z","timestamp":1715941988000},"page":"1227-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune reconstitution after transplantation of autologous peripheral stem cells in children: a comparison between CD34+ selected and nonmanipulated grafts"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2729-9941","authenticated-orcid":false,"given":"Tim","family":"Flaadt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0797-5452","authenticated-orcid":false,"given":"Christina","family":"Jaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-3460","authenticated-orcid":false,"given":"Claus-Philipp","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Amorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Gerhardt","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Eyrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Greil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.jcyt.2024.05.013_bib0001","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.05.013_bib0002","unstructured":"Pediatric autologous hematopoietic stem cell transplantation (PDQ(R)): health professional version. In PDQ cancer information summaries. 2002: Bethesda (MD)."},{"issue":"9","key":"10.1016\/j.jcyt.2024.05.013_bib0003","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","article-title":"Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial","volume":"6","author":"Berthold","year":"2005","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.jcyt.2024.05.013_bib0004","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood.V83.10.3085.3085","article-title":"Clonogenicity of circulating neuroblastoma cells: implications regarding peripheral blood stem cell transplantation","volume":"83","author":"Moss","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2024.05.013_bib0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V84.2.380.380","article-title":"Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells","volume":"84","author":"Rill","year":"1994","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jcyt.2024.05.013_bib0006","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.1996.14.8.2224","article-title":"Highly purified CD34-positive cells reconstitute hematopoiesis","volume":"14","author":"Civin","year":"1996","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jcyt.2024.05.013_bib0007","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1470-2045(13)70309-7","article-title":"Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial","volume":"14","author":"Kreissman","year":"2013","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.jcyt.2024.05.013_bib0008","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcyt.2024.05.013_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"10.1016\/j.jcyt.2024.05.013_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/10428199709039012","article-title":"The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation","volume":"24","author":"Domenech","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.jcyt.2024.05.013_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1700626","article-title":"Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow","volume":"19","author":"Talmadge","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2024.05.013_bib0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/scd.1.1997.6.235","article-title":"Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma","volume":"6","author":"Handgretinger","year":"1997","journal-title":"J Hematother"},{"issue":"9","key":"10.1016\/j.jcyt.2024.05.013_bib0013","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.bmt.1703536","article-title":"Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma","volume":"29","author":"Handgretinger","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2024.05.013_bib0014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1634\/theoncologist.2-6-410","article-title":"CD34+ selection: the basic component for graft engineering","volume":"2","author":"Miltenyi","year":"1997","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.jcyt.2024.05.013_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bmt.1701961","article-title":"Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children","volume":"24","author":"Lang","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jcyt.2024.05.013_bib0016","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1701228","article-title":"Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting","volume":"21","author":"Handgretinger","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2024.05.013_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/106161299320488","article-title":"Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device","volume":"8","author":"Schumm","year":"1999","journal-title":"J Hematother"},{"issue":"11","key":"10.1016\/j.jcyt.2024.05.013_bib0018","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701789","article-title":"Multicentre European study comparing selection techniques for the isolation of CD34+ cells","volume":"23","author":"de Wynter","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2024.05.013_bib0019","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2141.1999.01691.x","article-title":"Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study","volume":"107","author":"Lemoli","year":"1999","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.05.013_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2141.2000.01824.x","article-title":"Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants","volume":"108","author":"Rutella","year":"2000","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jcyt.2024.05.013_bib0021","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V91.7.2588","article-title":"Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors","volume":"91","author":"Bomberger","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2024.05.013_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/bbmt.2002.v8.pm12064366","article-title":"Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation","volume":"8","author":"Crippa","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2024.05.013_bib0023","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","article-title":"Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment","volume":"11","author":"Brodeur","year":"1993","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jcyt.2024.05.013_bib0024","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/scd.1.1995.4.307","article-title":"Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization","volume":"4","author":"Klingebiel","year":"1995","journal-title":"J Hematother"},{"key":"10.1016\/j.jcyt.2024.05.013_bib0025","first-page":"615","article-title":"Peripheral stem cell collection and transplantation in pediatric patients","volume":"377","author":"Handgretinger","year":"1992","journal-title":"Prog Clin Biol Res"},{"issue":"6","key":"10.1016\/j.jcyt.2024.05.013_bib0026","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40272-017-0251-3","article-title":"Incidence, survival, and treatment of localized and metastatic neuroblastoma in Germany 1979\u20132015","volume":"19","author":"Berthold","year":"2017","journal-title":"Paediatr Drugs"},{"issue":"3","key":"10.1016\/j.jcyt.2024.05.013_bib0027","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41416-018-0169-8","article-title":"Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation","volume":"119","author":"Berthold","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcyt.2024.05.013_bib0028","first-page":"309","article-title":"Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG","volume":"385","author":"Klingebiel","year":"1994","journal-title":"Prog Clin Biol Res"},{"issue":"4","key":"10.1016\/j.jcyt.2024.05.013_bib0029","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/cells9040811","article-title":"Directed differentiation of mobilized hematopoietic stem and progenitor cells into functional NK cells with enhanced antitumor activity","volume":"9","author":"Oberoi","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jcyt.2024.05.013_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.bmt.1704303","article-title":"Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases","volume":"33","author":"Lang","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2024.05.013_bib0031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jcyt.2024.05.013_bib0032","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbmt.2017.04.013","article-title":"Prognostic analysis of absolute lymphocyte and monocyte counts after autologous stem cell transplantation in children, adolescents, and young adults with refractory or relapsed Hodgkin lymphoma","volume":"23","author":"Galvez-Silva","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2024.05.013_bib0033","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2141.2006.06232.x","article-title":"Absolute lymphocyte count predicts overall survival in follicular lymphomas","volume":"134","author":"Siddiqui","year":"2006","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jcyt.2024.05.013_bib0034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MPH.0000000000000717","article-title":"Early lymphocyte recovery and outcome in osteosarcoma","volume":"39","author":"Lee","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jcyt.2024.05.013_bib0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbmt.2017.11.012","article-title":"Immune reconstitution following autologous stem cell transplantation in patients with high-risk neuroblastoma at the time of immunotherapy","volume":"24","author":"Nassin","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2024.05.013_bib0036","doi-asserted-by":"crossref","first-page":"e976","DOI":"10.1634\/theoncologist.2019-0898","article-title":"EMA recommendation for the pediatric indications of plerixafor (Mozobil) to enhance mobilization of hematopoietic stem cells for collection and subsequent autologous transplantation in children with lymphoma or malignant solid tumors","volume":"25","author":"Karres","year":"2020","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.jcyt.2024.05.013_bib0037","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/pbc.25507","article-title":"Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma","volume":"62","author":"van Wezel","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924007163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:10:44Z","timestamp":1745338244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924007163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1465324924007163"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.05.013","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune reconstitution after transplantation of autologous peripheral stem cells in children: a comparison between CD34+ selected and nonmanipulated grafts","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}